Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 2
pubmed Jul 22, 2003

Cathelicidins, multifunctional peptides of the innate immunity.

Zanetti. Margherita M

LL-37 is a natural protein fragment that kills microbes and also calls immune cells to sites of infection, helps skin wounds heal faster, and changes how some immune cells behave. Similar peptides in pigs and cows do related things like promoting blood vessel growth or killing abnormal cells. The study mainly describes what these peptides do in the body, not how to use them safely as a supplement or therapy.

Utility 2
pubmed Nov 22, 2001

Innate antimicrobial peptide protects the skin from invasive bacterial infection.

Nizet. V V; Ohtake. T T; Lauth. X X; Trowbridge. J J; Rudisill. J J; Dorschner. R A RA; Pestonjamasp...

This study shows that the natural antimicrobial peptide LL‑37 (and its mouse version CRAMP) helps protect skin from serious bacterial infections in mice, proving it’s an important part of the body’s first‑line defense.

Utility 2
pubmed Oct 20, 2000

Epithelial antimicrobial peptides in host defense against infection.

Bals. R R

LL‑37 is a natural peptide made by airway cells and immune cells that can kill microbes and also helps control inflammation, wound healing, and other immune processes. The paper reviews how these peptides work and suggests they could be used as new drug templates, but it doesn’t give specific dosing or supplement advice.

Utility 2
pubmed Feb 1, 2001

Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator.

Islam. D D; Bandholtz. L L; Nilsson. J J; Wigzell. H H; Christensson. B B; Agerberth. B B; Gudmundss...

During early Shigella infection, the body lowers the production of two key antimicrobial peptides, LL‑37 and human beta‑defensin‑1, which may let the bacteria stick to and invade gut cells. The study shows this happens both in patient tissue samples and lab-grown cells, and points to Shigella plasmid DNA as a trigger.

Utility 2
pubmed Jan 1, 2002

Cathelicidins: a family of endogenous antimicrobial peptides.

Lehrer. Robert I RI; Ganz. Tomas T

LL-37 is a natural peptide your body makes in immune cells and many other tissues. It can kill microbes and attract other immune cells, and scientists are looking at similar peptides as new medicines. Some animal versions have helped protect the heart in mice and reduce mouth sores during cancer treatment, but there’s no proven way for you to use LL-37 safely yet.

Utility 2
pubmed 2005

Pulmonary defense and the human cathelicidin hCAP-18/LL-37.

Fahy. R J RJ; Wewers. M D MD

LL-37 is a natural antimicrobial peptide that helps protect the lungs by killing germs and calming inflammation. Scientists are looking at it as a possible treatment for things like cystic fibrosis, oral sores, and severe infections, but the paper is a review and doesn’t give specific dosing or how to use it at home.

Utility 2
pubmed Oct 1, 2003

Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.

McPhee. Joseph B JB; Lewenza. Shawn S; Hancock. Robert E W RE

The study found that the human antimicrobial peptide LL‑37, like other positively‑charged peptides, triggers a bacterial sensor system (PmrA‑PmrB) in Pseudomonas aeruginosa, making the bacteria more resistant to those same peptides. In plain terms, giving LL‑37 to fight infection could actually help the bug learn to dodge it, which is a caution for anyone thinking about using LL‑37 as a supplement or antibiotic.

Utility 2
pubmed Mar 1, 2003

Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.

Di Nardo. Anna A; Vitiello. Antonella A; Gallo. Richard L RL

Mast cells, a type of immune cell, make the natural antibiotic peptide LL‑37 (cathelicidin). When they sense bacterial signals, they boost LL‑37 production, and this peptide is crucial for killing bacteria like group A strep. Mice lacking the gene for LL‑37 in mast cells are about half as good at killing these bacteria, showing LL‑37 is a key part of the mast cell’s antimicrobial arsenal.

Utility 2
pubmed 1998

Epithelial antimicrobial peptides: review and significance for oral applications.

Weinberg. A A; Krisanaprakornkit. S S; Dale. B A BA

This paper explains that our mouth’s lining makes natural antibiotics like LL‑37 and beta‑defensins, which help keep harmful microbes away and control inflammation. It shows these peptides are already present in gums and tongue and may be key to fighting oral infections, hinting they could become new treatments someday.

Utility 2
pubmed Dec 1, 2002

The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa.

Marchini. G G; Lindow. S S; Brismar. H H; Ståbi. B B; Berggren. V V; Ulfgren. A-K AK; Lonne-Rah...

The study shows that newborn babies already have strong natural antimicrobial defenses: the peptide LL‑37 and other antibacterial proteins are found in their skin and the creamy coating called vernix, and they can kill bacteria. In babies with a common skin rash (erythema toxicum), LL‑37 levels go up, suggesting it helps fight infection.

Utility 2
pubmed 2004

Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis.

Chen. Christiane I-U CI; Schaller-Bals. Susanne S; Paul. Karl P KP; Wahn. Ulrich U; Bals. Robert R

In people with cystic fibrosis, higher levels of the antimicrobial peptide LL‑37 in lung fluid are linked to more inflammation and worse lung function, while lower levels of other peptides (beta‑defensins) show up as the disease gets worse.

Utility 2
pubmed 2000

Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.

Yasin. B B; Pang. M M; Turner. J S JS; Cho. Y Y; Dinh. N N NN; Waring. A J AJ; Lehrer. R I RI; Wagar...

The study found that LL‑37, a common human antimicrobial peptide, barely stopped herpes simplex virus (HSV‑1 or HSV‑2) from infecting cells, so it isn’t useful as an anti‑herpes supplement. Some other natural peptides did work, but many are toxic or need more research.

Utility 2
pubmed Nov 5, 2004

Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk.

Murakami. Masamoto M; Dorschner. Robert A RA; Stern. Lauren J LJ; Lin. Kenneth H KH; Gallo. Richard...

The study shows that the antimicrobial peptide LL-37 is naturally produced in the mammary gland and ends up in human milk, where it can kill common bacteria like Staph aureus and E. coli. This confirms that LL-37 contributes to milk’s natural infection‑fighting properties.

Utility 2
pubmed Apr 1, 2004

The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins.

Fernie-King. Barbara A BA; Seilly. David J DJ; Lachmann. Peter J PJ

The study shows that a bacterial protein called SIC can block the antimicrobial activity of several human beta‑defensins (hBD‑1, hBD‑2, hBD‑3) and also the cathelicidin LL‑37, which are natural peptides that help kill harmful bacteria. SIC binds strongly to hBD‑2 and hBD‑3, but not to hBD‑1, and this binding is affected by the salt level of the surrounding fluid.

Utility 2
pubmed Aug 1, 2005

The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.

Niyonsaba. François F; Ushio. Hiroko H; Nagaoka. Isao I; Okumura. Ko K; Ogawa. Hideoki H

The study shows that the skin peptide LL-37 (and some related defensins) makes skin cells release a signaling molecule called IL-18 by turning on specific cell pathways (p38 and ERK). This happens quickly (within a few hours) and works better when the peptides are combined. The effect does not need the usual enzyme (caspase‑1) that usually helps release IL‑18.

Utility 2
pubmed 2006

Cytokines, skin, and smallpox-a new link to an antimicrobial Peptide.

Harrison. Jodie M JM; Ramshaw. Ian A IA

People with atopic dermatitis (eczema) are more likely to get viral infections because the chemicals in their skin stop the body from making the natural antimicrobial peptide LL‑37, which helps fight viruses like smallpox.

Utility 2
pubmed 2022

The effects of Malassezia in the activation of Interleukin (IL)-23/IL-17 axis in Psoriasis.

Fang. HuaLi H; Hou. YingDou Y; Zhuang. Hui H; Wang. ChengHong C

The study shows that people with psoriasis who have more Malassezia fungus on their skin also have higher levels of the antimicrobial peptide LL‑37 and inflammatory signals (IL‑23, IL‑17A, TNF‑α), which makes their skin condition worse. Treating the fungus with an antifungal drug (ketoconazole) lowered the skin inflammation and improved the psoriasis severity score.

Utility 2
pubmed 2018

Human cathelicidin LL-37 - Does it influence the homeostatic imbalance in mental disorders?

Kozlowska. Elzbieta E; Wysokinski. Adam A; Majewski. Karol K; Agier. Justyna J; Margulska. Aleksandr...

The study measured the blood protein LL‑37 in people with schizophrenia, bipolar disorder, pneumonia, tuberculosis and healthy folks. It found that people with schizophrenia had lower LL‑37 than those with bipolar disorder or TB, while bipolar patients had higher levels than infection groups. The authors think these differences reflect a broader imbalance in the body’s immune and metabolic systems that might relate to mental illness.